|
1
|
Brocklehurst PR, Baker SR and Speight PM:
Oral cancer screening: What have we learnt and what is there still
to achieve? Future Oncol. 6:299–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hui Y, Li Y, Jing Y, Feng JQ and Ding Y:
miRNA-101 acts as a tumor suppressor in oral squamous cell
carcinoma by targeting CX chemokine receptor 7. Am J Transl Res.
8:4902–4911. 2016.PubMed/NCBI
|
|
3
|
Pérez-Sayáns M, Suárez-Peñaranda JM,
Padin-Iruegas ME, Gayoso-Diz P, Reis-De Almeida M, Barros-Angueira
F, Gándara-Vila P, Blanco-Carrión A and García-García A: The loss
of p16 expression worsens the prognosis of OSCC. Appl
Immunohistochem Mol Morphol. 23:724–732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Walden MJ and Aygun N: Head and neck
cancer. Semin Roentgenol. 48:75–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sinha N, Mukhopadhyay S, Das DN, Panda PK
and Bhutia SK: Relevance of cancer initiating/stem cells in
carcinogenesis and therapy resistance in oral cancer. Oral Oncol.
49:854–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo T and Califano JA: Molecular biology
and immunology of head and neck cancer. Surg Oncol Clin N Am.
24:397–407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY,
Lin SC, Liu CJ, Chen YS, Lo JF and Yu CC: Elimination of head and
neck cancer initiating cells through targeting glucose regulated
protein78 signaling. Mol Cancer. 9:2832010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hitt R and Echarri MJ: Molecular biology
in head and neck cancer. Clin Transl Oncol. 8:776–779. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie B, Ding Q, Han H and Wu D: miRCancer:
A microRNA-cancer association database constructed by text mining
on literature. Bioinformatics. 29:638–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhai L, Li Y, Lan X and Ai L:
MicroRNA-10a-5p suppresses cancer proliferation and division in
human cervical cancer by targeting BDNF. Exp Ther Med.
14:6147–6151. 2017.PubMed/NCBI
|
|
14
|
Huang J, He Y, McLeod HL, Xie Y, Xiao D,
Hu H, Chen P, Shen L, Zeng S, Yin X, et al: miR-302b inhibits
tumorigenesis by targeting EphA2 via Wnt/β-catenin/EMT signaling
cascade in gastric cancer. BMC Cancer. 17:8862017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang YJ, Zhang ZF, Fan SH, Zhuang J, Shan
Q, Han XR, Wen X, Li MQ, Hu B, Sun CH, et al: MicroRNA-433 inhibits
oral squamous cell carcinoma cells by targeting FAK. Oncotarget.
8:100227–100241. 2017.PubMed/NCBI
|
|
16
|
Wang T, Ren Y, Liu R, Ma J, Shi Y, Zhang L
and Bu R: miR-195-5p suppresses the proliferation, migration, and
invasion of oral squamous cell carcinoma by targeting TRIM14.
Biomed Res Int. 2017:73781482017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu B, Chen W, Cao G, Dong Z, Xu J, Luo T
and Zhang S: MicroRNA-27b inhibits cell proliferation in oral
squamous cell carcinoma by targeting FZD7 and Wnt signaling
pathway. Arch Oral Biol. 83:92–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weng J, Zhang H, Wang C, Liang J, Chen G,
Li W, Tang H and Hou J: miR-373-3p targets DKK1 to promote
EMT-induced metastasis via the Wnt/β-catenin pathway in
tongue squamous cell carcinoma. Biomed Res Int. 2017:60109262017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang C, Yun Z, Zhao T, Liu X and Ma X:
MiR-495 is a predictive biomarker that downregulates GFI1
expression in medulloblastoma. Cell Physiol Biochem. 36:1430–1439.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mao Y, Li L, Liu J, Wang L and Zhou Y:
MiR-495 inhibits esophageal squamous cell carcinoma progression by
targeting Akt1. Oncotarget. 7:51223–51236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen SM, Chen HC, Chen SJ, Huang CY, Chen
PY, Wu TW, Feng LY, Tsai HC, Lui TN, Hsueh C and Wei KC:
MicroRNA-495 inhibits proliferation of glioblastoma multiforme
cells by downregulating cyclin-dependent kinase 6. World J Surg
Oncol. 11:872013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B, Yuan F, Liu J, Li Y, Zhou F, Liu
X, Hao Z, Li Q, Zheng Y and Wang W: Hsa-miR-495 acts as a tumor
suppressor gene in glioma via the negative regulation of MYB. Mol
Med Rep. 14:977–982. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang W, Zheng J, Yu T and Wang J:
Overexpression of microRNA-495 suppresses the proliferation and
invasion and induces the apoptosis of osteosarcoma cells by
targeting high-mobility group nucleosome-binding domain 5. Oncol
Rep. 38:1099–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang S, Fan H, Xu J and Zhao E: Prognostic
implication of NOTCH1 in early stage oral squamous cell cancer with
occult metastases. Clin Oral Investig. 22:1131–1138. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoshida R, Nagata M, Nakayama H,
Niimori-Kita K, Hassan W, Tanaka T, Shinohara M and Ito T: The
pathological significance of Notch1 in oral squamous cell
carcinoma. Lab Invest. 93:1068–1081. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gan RH, Wei H, Xie J, Zheng DP, Luo EL,
Huang XY, Xie J, Zhao Y, Ding LC, Su BH, et al: Notch1 regulates
tongue cancer cells proliferation, apoptosis and invasion. Cell
Cycle. 17:216–224. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Natsuizaka M, Whelan KA, Kagawa S, Tanaka
K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS,
Que J, et al: Interplay between Notch1 and Notch3 promotes EMT and
tumor initiation in squamous cell carcinoma. Nat Commun.
8:17582017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhong R, Bao R, Faber PW, Bindokas VP,
Bechill J, Lingen MW and Spiotto MT: Notch1 activation or loss
promotes HPV-induced oral tumorigenesis. Cancer Res. 75:3958–3969.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rastogi B, Kumar A, Raut SK, Panda NK,
Rattan V, Joshi N and Khullar M: Downregulation of miR-377 promotes
oral squamous cell carcinoma growth and migration by targeting
HDAC9. Cancer Invest. 35:152–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan Y, Wang X, Venø MT, Bakholdt V,
Sørensen JA, Krogdahl A, Sun Z, Gao S and Kjems J: Circulating
miRNAs as biomarkers for oral squamous cell carcinoma recurrence in
operated patients. Oncotarget. 8:8206–8214. 2017.PubMed/NCBI
|
|
34
|
Manikandan M, Deva Magendhra Rao AK,
Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R and
Munirajan AK: Oral squamous cell carcinoma: microRNA expression
profiling and integrative analyses for elucidation of
tumourigenesis mechanism. Mol Cancer. 15:282016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan L, Yao J and Qiu J: miRNA-495
suppresses proliferation and migration of colorectal cancer cells
by targeting FAM83D. Biomed Pharmacother. 96:974–981. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bai Z, Wang J, Wang T, Li Y, Zhao X, Wu G,
Yang Y, Deng W and Zhang Z: The miR-495/Annexin A3/p53 axis
inhibits the invasion and EMT of colorectal cancer cells. Cell
Physiol Biochem. 44:1882–1895. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eun JW, Kim HS, Shen Q, Yang HD, Kim SY,
Yoon JH, Park WS, Lee JY and Nam SW: MicroRNA-495-3p functions as a
tumor suppressor by regulating multiple epigenetic modifiers in
gastric carcinogenesis. J Pathol. 244:107–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, Zhu
G, Liu Z, Tu Y, Peng G, et al: miR-495 and miR-551a inhibit the
migration and invasion of human gastric cancer cells by directly
interacting with PRL-3. Cancer Lett. 323:41–47. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang H, Jiang Z, Chen H, Wu X, Xiang J and
Peng J: MicroRNA-495 inhibits gastric cancer cell migration and
invasion possibly via targeting high mobility group AT-Hook 2
(HMGA2). Med Sci Monit. 23:640–648. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li JZ, Wang ZL, Xu WH, Li Q, Gao L and
Wang ZM: MicroRNA-495 regulates migration and invasion in prostate
cancer cells via targeting Akt and mTOR signaling. Cancer Invest.
34:181–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu YY, Tian J, Hao Q and Yin LR:
MicroRNA-495 downregulates FOXC1 expression to suppress cell growth
and migration in endometrial cancer. Tumour Biol. 37:239–251. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lv C, Bai Z, Liu Z, Luo P and Zhang J:
MicroRNA-495 suppresses human renal cell carcinoma malignancy by
targeting SATB1. Am J Transl Res. 7:1992–1999. 2015.PubMed/NCBI
|
|
43
|
Tan M, Mu X, Liu Z, Tao L, Wang J, Ge J
and Qiu J: microRNA-495 promotes bladder cancer cell growth and
invasion by targeting phosphatase and tensin homolog. Biochem
Biophys Res Commun. 483:867–873. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao M, Nie W, Li J, Zhang Y, Yan X, Guan
X, Chen X, Zen K, Zhang CY, Jiang X and Hou D: MicroRNA-495 induces
breast cancer cell migration by targeting JAM-A. Protein Cell.
5:862–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zou Z, Zou R, Zong D, Shi Y, Chen J, Huang
J, Zhu J, Chen L, Bao X, Liu Y, et al: miR-495 sensitizes MDR
cancer cells to the combination of doxorubicin and taxol by
inhibiting MDR1 expression. J Cell Mol Med. 21:1929–1943. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hwang-Verslues WW, Chang PH, Wei PC, Yang
CY, Huang CK, Kuo WH, Shew JY, Chang KJ, Lee EY and Lee WH: miR-495
is upregulated by E12/E47 in breast cancer stem cells, and promotes
oncogenesis and hypoxia resistance via downregulation of E-cadherin
and REDD1. Oncogene. 30:2463–2474. 2011. View Article : Google Scholar : PubMed/NCBI
|
